Lung transplantation for chronic thromboembolic pulmonary hypertension
Therapeutic advances in chronic thromboembolic pulmonary hypertension (CTEPH) over the last 10 years have improved patient prognosis. As a result, the role of lung transplantation (LTx) for this indication has been greatly reduced. In this review article, we describe the evolution of treatments for CTEPH, the place that remains for lung transplantation, and the particularities of lung transplantation for this indication.
Authors
- Tom Verbelen (ORCID: https://orcid.org/0000-0003-1461-3986)
- Laurent Godinas (ORCID: https://orcid.org/0000-0003-2214-5879)
- Élie Fadel (ORCID: https://orcid.org/0000-0002-9290-4589)
- Emanuele Muscogiuri (ORCID: https://orcid.org/0000-0001-8844-8210)
- Michaela Orlitová (ORCID: https://orcid.org/0000-0002-5295-9315)
- Marion Delcroix (ORCID: https://orcid.org/0000-0001-8394-9809)
- Laurens J. Ceulemans (ORCID: https://orcid.org/0000-0002-4261-7100)
Institutions
- Centre Chirurgical Marie Lannelongue (FR)
- KU Leuven (BE)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100461
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00